Reasanz
Country: European Union
Language: Dutch
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
01-09-2014
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Serelaxin
Available from:
Novartis Europharm Ltd
ATC code:
C01DX21
INN (International Name):
serelaxin
Therapeutic group:
Andere vasodilatoren gebruikt in de cardiale ziekten
Therapeutic area:
Hartfalen
Therapeutic indications:
Behandeling van acuut hartfalen.
Authorization status:
geweigerd
